| 000 | 01147 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250516055524.0 | ||
| 264 | 0 | _c20111220 | |
| 008 | 201112s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2011.36.1840 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLipshitz, Jay | |
| 245 | 0 | 0 |
_aMisunderstanding regarding the carboplatin dose comparison in MRC TE19/EORTC 30982. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cNov 2011 |
||
| 300 |
_a4211; author reply 4211-2 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarboplatin _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOrchiectomy |
| 650 | 0 | 4 |
_aSeminoma _xtherapy |
| 650 | 0 | 4 |
_aTesticular Neoplasms _xtherapy |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 29 _gno. 31 _gp. 4211; author reply 4211-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2011.36.1840 _zAvailable from publisher's website |
| 999 |
_c21185351 _d21185351 |
||